DudeDiligence.

Alector, Inc

ALECNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price

From the filings

Figures

Revenue
$173.5Mlast 12 months
Net income
$41.4Mlast 12 months
Operating cash flow
−$158.2Mlast 12 months
Cash and equivalents
$75.5Mat the last balance sheet
Total debt
$0.00at the last balance sheet
Shares outstanding
112.3M shareson issue
Every year and quarter →